A detailed history of Flputnam Investment Management CO transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Flputnam Investment Management CO holds 144,178 shares of BMY stock, worth $8.33 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
144,178
Previous 149,739 3.71%
Holding current value
$8.33 Million
Previous $6.22 Million 19.99%
% of portfolio
0.13%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$39.66 - $51.75 $220,549 - $287,781
-5,561 Reduced 3.71%
144,178 $7.46 Million
Q2 2024

Aug 14, 2024

BUY
$40.25 - $52.99 $1.63 Million - $2.15 Million
40,483 Added 37.05%
149,739 $6.22 Million
Q1 2024

May 03, 2024

BUY
$47.98 - $54.4 $611,745 - $693,600
12,750 Added 13.21%
109,256 $5.92 Million
Q4 2023

Jan 30, 2024

BUY
$48.48 - $57.85 $550,344 - $656,713
11,352 Added 13.33%
96,506 $4.95 Million
Q3 2023

Nov 06, 2023

SELL
$57.89 - $64.73 $1.86 Million - $2.08 Million
-32,209 Reduced 27.44%
85,154 $4.94 Million
Q2 2023

Aug 14, 2023

SELL
$63.71 - $70.74 $2.02 Million - $2.24 Million
-31,701 Reduced 21.27%
117,363 $7.51 Million
Q1 2023

Apr 27, 2023

SELL
$65.71 - $74.53 $562,609 - $638,125
-8,562 Reduced 5.43%
149,064 $10.3 Million
Q4 2022

Jan 31, 2023

BUY
$68.48 - $81.09 $3.38 Million - $4.01 Million
49,393 Added 45.64%
157,626 $11.3 Million
Q3 2022

Nov 07, 2022

BUY
$0.13 - $76.84 $6,364 - $3.76 Million
48,956 Added 82.59%
108,233 $7.69 Million
Q2 2022

Aug 08, 2022

BUY
$72.62 - $79.98 $38,851 - $42,789
535 Added 0.91%
59,277 $4.56 Million
Q1 2022

Apr 28, 2022

BUY
$61.48 - $73.72 $369,679 - $443,278
6,013 Added 11.4%
58,742 $4.29 Million
Q4 2021

Feb 15, 2022

BUY
$53.63 - $62.52 $123,563 - $144,046
2,304 Added 4.57%
52,729 $3.29 Million
Q3 2021

Oct 26, 2021

SELL
$59.17 - $69.31 $9,348 - $10,950
-158 Reduced 0.31%
50,425 $2.98 Million
Q2 2021

Aug 11, 2021

SELL
$61.91 - $67.42 $108,218 - $117,850
-1,748 Reduced 3.34%
50,583 $3.38 Million
Q1 2021

May 14, 2021

SELL
$59.34 - $66.74 $323,284 - $363,599
-5,448 Reduced 9.43%
52,331 $3.3 Million
Q4 2020

Feb 02, 2021

BUY
$57.74 - $65.43 $27,541 - $31,210
477 Added 0.83%
57,779 $3.58 Million
Q3 2020

Nov 03, 2020

SELL
$57.43 - $63.64 $185,613 - $205,684
-3,232 Reduced 5.34%
57,302 $3.46 Million
Q2 2020

Aug 13, 2020

BUY
$54.82 - $64.09 $498,807 - $583,154
9,099 Added 17.69%
60,534 $3.56 Million
Q1 2020

May 08, 2020

BUY
$46.4 - $67.43 $495,366 - $719,882
10,676 Added 26.19%
51,435 $2.87 Million
Q4 2019

Jan 30, 2020

BUY
$49.21 - $64.19 $572,213 - $746,401
11,628 Added 39.92%
40,759 $2.62 Million
Q3 2019

Nov 05, 2019

BUY
$42.77 - $50.71 $428,042 - $507,505
10,008 Added 52.33%
29,131 $1.48 Million
Q2 2019

Jul 25, 2019

SELL
$44.62 - $49.34 $1,874 - $2,072
-42 Reduced 0.22%
19,123 $867,000
Q1 2019

May 15, 2019

BUY
$45.12 - $53.8 $62,310 - $74,297
1,381 Added 7.77%
19,165 $914,000
Q4 2018

Feb 22, 2019

BUY
$48.76 - $63.23 $128,531 - $166,674
2,636 Added 17.4%
17,784 $924,000
Q3 2018

Nov 13, 2018

BUY
$55.19 - $62.25 $206,686 - $233,126
3,745 Added 32.84%
15,148 $940,000
Q2 2018

Aug 01, 2018

SELL
$50.53 - $62.98 $775,938 - $967,120
-15,356 Reduced 57.39%
11,403 $631,000
Q1 2018

May 01, 2018

SELL
$59.92 - $68.98 $102,343 - $117,817
-1,708 Reduced 6.0%
26,759 $1.69 Million
Q4 2017

Feb 06, 2018

BUY
$59.94 - $65.35 $42,797 - $46,659
714 Added 2.57%
28,467 $1.74 Million
Q3 2017

Nov 07, 2017

BUY
$55.23 - $63.74 $1.53 Million - $1.77 Million
27,753
27,753 $1.77 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Flputnam Investment Management CO Portfolio

Follow Flputnam Investment Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Flputnam Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Flputnam Investment Management CO with notifications on news.